Ben Lauffer

Ben Lauffer is a Clinical Biomarker Operations Leader with a decade of experience in the biopharma industry, focusing on clinical and non-clinical translational biomarker plans. Lauffer's background includes roles at Genentech, where they managed projects in oncology, immunology, and neuroscience, and contributed to the development and execution of strategies across various clinical trials. They hold a PhD in Pharmaceutical Sciences from the University of California, San Francisco, and a B.S. in Animal Science from Cornell University, along with postdoctoral training in cellular pharmacology and pharmacogenomics.